Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Stress Response

May 4, 2017 updated by: May Mohamed Abdalla, Cairo University

Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Surgical Stress Response Using BIS

It is hypothesized that propofol, when used in general anesthesia (GA) influence patient's stress status and consequently affect stress response parameters. Hence, the objective of the presented research is to assess whether the propofol has anti-stress effect or not in patients undergoing surgeries that require GA and classified as The American Society of Anesthesiologists physical status 1 (ASA PS1)

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

  • Forty patients will be divided into two groups of patients (n=20 each), where in the first group anesthesia induction will be with propofol as a single agent, while patients in the second group will be anesthetized by propofol/fentanyl and the depth of anesthesia will be determined by BIS score and will be kept at 40-60.
  • In both groups, blood will be withdrawn to assess the possible effect of these medications on stress by measuring the following parameters:

I- Hemodynamic indicators II- Catecholamines . III- Fasting blood glucose IV- Insulin level V- Cortisol VI- Vasopressin

VII- Cytokines:

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Kasr al aini
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

ASA1

Exclusion Criteria:

  • Patients who refused to participate in the study or to sign the consent form
  • The very young and very old patients
  • Severely agitated (panicked).
  • ASA1 patients who had bradycardia during propofol induction and was reversed with atropine.
  • Patients with any of the following pathologies: liver, kidney, lung, or cardiac diseases, allergic to medicines, alcohol abuse, pregnant, or having endocrine or neuropsychiatric diseases. Moreover, those with sepsis syndrome with hemodynamic instability, hypothermia, and poorly controlled coagulopathy will not be enrolled in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: propofol
this arm will receive propofol in induction of anesthesia and blood sample will be withdrawn before induction and another sample will be withdrawn after induction with 3 mins
I.V propofol
Active Comparator: propofol and fentanyl
this arm will receive propofol and fentanyl in induction of anesthesia and blood sample will be withdrawn before induction and another sample will be withdrawn after induction with 3 mins
Other Names:
  • propofol
I.V propofol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary end point; assessment of change in blood biochemical indicators of surgical stress
Time Frame: blood sample will withdrawn before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins

blood testing includes: Catecholamines 1. Epinephrine 2. Nor epinephrine

, Fasting blood glucose, Insulin level, Cortisol, Vasopressin, and Cytokines

blood sample will withdrawn before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins

Secondary Outcome Measures

Outcome Measure
Time Frame
Secondary end point; assessment of change in BIS number
Time Frame: BIS readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins
BIS readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins
Tertiary end point; assessment of change in blood pressure
Time Frame: blood pressure readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins
blood pressure readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins
Quaternary end point; assessment of change in heart rate
Time Frame: heart rate readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins
heart rate readings will be recorded before induction of anesthesia with 10 mins and after induction of anesthesia with 3 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2016

Primary Completion (Anticipated)

July 1, 2017

Study Completion (Anticipated)

September 1, 2017

Study Registration Dates

First Submitted

April 22, 2017

First Submitted That Met QC Criteria

May 4, 2017

First Posted (Actual)

May 8, 2017

Study Record Updates

Last Update Posted (Actual)

May 8, 2017

Last Update Submitted That Met QC Criteria

May 4, 2017

Last Verified

May 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Fentanyl

3
Subscribe